CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Shares withheld for taxes Chief Executive Officer gave up 71,406 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Other events
- 8-K Event Material agreement · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Open-market sale Director sold 3,900 shares at $10.04 ($39,156)
- 4 Open-market sale Director sold 20,000 shares at an average $9.07 ($181,391)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Material agreement · New debt or obligation · Other events
- 4 Open-market buy 10% owner bought 52,500 shares at $8.45 ($443,363)
- 8-K Event Other events
- 4 Open-market buy 10% owner bought 72,500 shares at an average $8.62 ($624,697)
- 8-K Event Material agreement · Other events
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
Page 13 of 44 · 872 filings